> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# FDA Clears Applied BioCode Respiratory Pathogen Panel
- URL: https://www.fdaweb.com/fda-clears-applied-biocode-respiratory-pathogen-panel/
- Published: 2020-01-06T12:00:00.000Z
- Updated: 2026-09-14T15:57:18.000Z
- Author: David McFarland
- Tags: Devices, #legacy-id-D5145770

FDA has cleared an Applied BioCode 510(k) for its BioCode Respiratory Pathogen Panel (RPP) for use on the BioCode MDx-3000 System. The RPP tests nasopharyngeal swabs for of the most common viruses and bacteria, including Influenza A and subtypes H1, H1N1 2009pdm and H3, Influenza B, respiratory syncytial virus A/B, parainfluenza virus Types 1, 2, 3, and 4, human metapneumovirus A/B, adenovirus, rhinovirus/enterovirus, coronavirus, *Mycoplasma pneumoniae*, *Chlamydia pneumoniae*, and *Bordetella pertussis*. Previously, FDA cleared the company’s 17-target BioCode Gastrointestinal Pathogen Panel (GPP). The MDx-3000 system allows users to run the RPP and GPP combo panels at the same time, according to the company.